AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, in combination with chemotherapy in adult patients with advanced solid tumors

被引：0
|
作者：
Mita, A. C.
Wang, D.
Takimoto, C. H.
Malseed, E.
Nguyen, L.
Rasmussen, E.
Storgard, C.
LoRusso, P.
机构：
[1] Inst Drug Dev, San Antonio, TX USA
[2] Wayne State Karmanos Canc Inst, Detroit, MI USA
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14033
引用
收藏
页数：1
相关论文
共 50 条
  • [41] COMBINATION CHEMOTHERAPY FOR ADVANCED SOLID TUMORS WITH METHYL-CCNU AND BETA-2'-DEOXYTHIOGUANOSINE
    BROOKS, JC
    KAUFMAN, J
    DOUGLASS, HO
    CANCER TREATMENT REPORTS, 1976, 60 (07): : 965 - 966
  • [42] Safety and pharmacokinetics (PK) of AMG 479 in combination with erlotinib (E) or sorafenib (S) in patients (pts) with advanced solid tumors.
    Puzanov, I.
    Sarantopoulos, J.
    Gilbert, J.
    Mahalingam, D.
    Chap, L. I.
    Deng, H.
    Zhu, M.
    McCaffery, I.
    Friberg, G. R.
    Rosen, L. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [43] Phase I evaluation of the safety of conatumumab (AMG 655) in combination with ARM 479 in patients (pts) with advanced, refractory solid tumors
    Chawla, S. P.
    Tabernero, J.
    Kindler, H. L.
    Chiorean, E. G.
    LoRusso, P.
    Hsu, M.
    Haddad, V.
    Bach, B. A.
    Baselga, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [44] A phase 1b/2 study of ramucirumab in combination with emibetuzumab in patients with advanced solid tumors
    Bendell, Johanna
    Fuchs, Charles
    Voss, Martin
    Bauer, Todd M.
    Choueiri, Toni K.
    Drilon, Alexander
    Thorn, Katharine
    Wijayawardana, Sameera
    Moser, Brian
    Urunuela, Arantxa
    Wacheck, Volker
    Harding, James J.
    CANCER RESEARCH, 2017, 77
  • [45] Phase I Study of AMG 337, a Highly Selective Small-molecule MET Inhibitor, in Patients with Advanced Solid Tumors
    Hong, David S.
    LoRusso, Patricia
    Hamid, Omid
    Janku, Filip
    Kittaneh, Muaiad
    Catenacci, Daniel V. T.
    Chan, Emily
    Bekaii-Saab, Tanios
    Gadgeel, Shirish M.
    Loberg, Robert D.
    Amore, Benny M.
    Hwang, Yuying C.
    Tang, Rui
    Ngarmchamnanrith, Gataree
    Kwak, Eunice L.
    CLINICAL CANCER RESEARCH, 2019, 25 (08) : 2403 - 2413
  • [46] Evaluation of pharmacokinetic (PK) drug-drug interactions (DDI) between trebananib (AMG 386) and paclitaxel (PTX) in patients (pts) with advanced solid tumors.
    Diamond, Jennifer Robinson
    Agarwal, Neeraj
    Bowles, Daniel W.
    Lam, Elaine Tat
    Werner, Theresa Louise
    Wu, Benjamin
    Rasmussen, Erik
    Gamelin, Erick
    Soto, Felipe
    Friberg, Gregory R.
    Sun, Yu-Nien
    Sharma, Sunil
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [47] A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041)
    Joanne W. Chiu
    Sebastien J. Hotte
    Christian K. Kollmannsberger
    Daniel J. Renouf
    David W. Cescon
    David Hedley
    Sue Chow
    Jeffrey Moscow
    Zhuo Chen
    Meghan Perry
    Ivan Diaz-Padilla
    David Tan
    Hal Hirte
    Elaine McWhirter
    Helen Chen
    Lillian L. Siu
    Philippe L. Bedard
    Investigational New Drugs, 2016, 34 : 104 - 111
  • [48] Phase I study of GS-5745 alone and in combination with chemotherapy in patients with advanced solid tumors
    Bendell, Johanna C.
    Starodub, Alexander
    Shah, Manish A.
    Sharma, Sunil
    Wainberg, Zev A.
    Thai, Dung Luong
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [49] Sunitinib in combination with mFOLFOX6 chemotherapy in patients with advanced solid tumors: A phase I study
    Leong, S.
    Eckhardt, S.
    Chan, E.
    Chow, L.
    VerMeulen, W.
    Camidge, D.
    Rothenberg, M.
    Chow Maneval, E.
    Chao, R.
    Lockhart, A.
    ANNALS OF ONCOLOGY, 2007, 18 : VII123 - VII123
  • [50] First-in-human study of AMG 655, a pro-apoptotic TRAIL receptor-2 agonist, in adult patients with advanced solid tumors
    LoRusso, P.
    Hong, D.
    Heath, E.
    Kurzrock, R.
    Wang, D.
    Hsu, M.
    Goyal, L.
    Wiezorek, J.
    Storgard, C.
    Herbst, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345